SecBot SecBot
144 ·Filed Jun 30, 2026

PYXS

Pyxis Oncology, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001959173-26-004977
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine director sale following an option exercise, no material signal. Monitor for actual Form 4 filings to confirm whether the sale was executed. The small size relative to market cap and director status (not CEO/CFO) suggests no bearish read-through.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$2.85
T+0 close · Jun 30, 2026 · via day close
Latest settled
+2.46%
T+60 · $2.92
Vs SPY
−0.50%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 1 $2.85entry
  2. T+1 · 5mo ago −7.72%α −7.59% · $2.63
  3. T+5 · 4mo ago +7.72%α +7.46% · $3.07
  4. T+20 · 4mo ago +2.46%α +4.64% · $2.92
  5. T+60 · 8w ago +2.46%α −0.50% · $2.92
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Jakob Dupont filed a Form 144 on June 30, 2026, indicating intent to sell 35,000 shares of Pyxis Oncology common stock, valued at approximately $107,034. The shares were acquired via a stock option exercise on the same day. This is a routine director sale following an option exercise and does not signal a change in company fundamentals.

Key Facts

  • Director Jakob Dupont filed Form 144 to sell 35,000 shares of Pyxis Oncology common stock.
  • Estimated sale value is approximately $107,034 based on the filing date.
  • Shares were acquired via stock option exercise on June 30, 2026.
  • The sale is to be executed through Fidelity Brokerage Services LLC.
  • The filing represents intent to sell, not a completed transaction.

Financial Impact

Proposed sale of 35,000 shares valued at ~$107K, representing ~0.06% of shares outstanding (based on 63.4M shares outstanding per filing).

dilutioninsider holdings

Risk Factors

  • Insider sale could be perceived negatively by retail traders despite routine nature.
  • If additional insider sales cluster in coming weeks, it could signal reduced confidence.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-004977
Document: 0001959173-26-004977-index.html0001959173-26-004977
Document: 0001959173-26-004977.txt0001959173-26-004977

Track record

25 reports on PYXS

Performance horizon

6 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +42.94% at T+60 after the Apr 17, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $1.43 Now $1.41 −1.32% settles Dec 16
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.43 Now $1.41 −1.40% settles Dec 16
  3. Nov 16, 2026today SC 13G Neutral 4/10 Entry $1.55 Now $1.41 −9.14% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 Entry $1.61 Now $1.41 −12.42% settles Dec 4
  5. Nov 3, 202613d ago SC 13G/A Bearish 5/10 Entry $1.64 Now $1.41 +14.02% settles Dec 2
  6. Oct 27, 202620d ago Press Release Neutral 4/10 Entry $1.84 Now $1.41 −23.37% settles Nov 24
  7. Oct 21, 202626d ago DEF 14A Bearish 6/10 Entry $1.71 Now $1.41 +17.54% settles Nov 19
  8. Oct 9, 20265w ago SC 13G/A Neutral 4/10 Entry $2.03 to $1.66 Now $1.41 −30.54% ▼ −18.23% −12.67% vs SPY
  9. Oct 2, 20266w ago SC 13G/A Neutral 4/10 Entry $2.14 to $1.81 Now $1.41 −34.11% ▼ −15.42% −13.61% vs SPY
  10. Oct 2, 20266w ago Press Release Bearish 7/10 Entry $2.14 to $1.81 Now $1.41 +34.11% ▲ +15.42% +13.61% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens in 6h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 3, 2026